Sedation and Neuromuscular Blockade in Acute Respiratory Distress Syndrome: A Step Toward Disentangling Best Practices
- PMID: 34135282
- DOI: 10.1097/CCM.0000000000005002
Sedation and Neuromuscular Blockade in Acute Respiratory Distress Syndrome: A Step Toward Disentangling Best Practices
Conflict of interest statement
Dr. Jabaley has disclosed that he does not have any potential conflicts of interest.
Comment on
-
Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for Treatment of Acute Respiratory Distress Syndrome-A Retrospective Cohort Study From a New England Health Care Network.Crit Care Med. 2021 Jul 1;49(7):1137-1148. doi: 10.1097/CCM.0000000000004951. Crit Care Med. 2021. PMID: 33710031
References
-
- Pun BT, Balas MC, Barnes-Daly MA, et al. Caring for critically ill patients with the ABCDEF bundle: Results of the ICU liberation collaborative in over 15,000 adults. Crit Care Med. 2019; 47:3–14
-
- Olsen HT, Nedergaard HK, Strøm T, et al. Nonsedation or light sedation in critically ill, mechanically ventilated patients. N Engl J Med. 2020; 382:1103–1111
-
- Papazian L, Forel JM, Gacouin A, et al.; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010; 363:1107–1116
-
- Moss M, Huang DT, Brower RG, et al.; National Heart, Lung, and Blood Institute PETAL Clinical Trials Network. Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med. 2019; 380:1997–2008
-
- Slutsky AS, Villar J. Early paralytic agents for ARDS? yes, no, and sometimes. N Engl J Med. 2019; 380:2061–2063
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical